4D Path vs Degron Therapeutics

4D Path vs Degron Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 4D Path is on 59/100 and Degron Therapeutics on 62/100.

4D Path logo
4D PathPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.
Try 4D Path
Degron Therapeutics logo
Degron TherapeuticsClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Try Degron Therapeutics

Where each one leads

4D Path

  • agent readiness: 30/100 against 27/100

Degron Therapeutics

  • domain rating: 24/100 against 9/100
  • headcount: 24 against 17
  • funding raised: $40.0M against $17.4M

At a glance

Measure4D PathDegron Therapeutics
What it isPersonalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
CategoryBiotechnology, HealthTech, Artificial Intelligence, Cancer ResearchBiotechnology, Pharmaceuticals, Drug Discovery, Healthcare
Sells toBusiness modelB2B2CB2B
OfferingPlatformPlatform
Founded20162020
HeadquartersNewton, USASan Diego, USA
StatusActiveActive

Size, funding and growth

Measure4D PathDegron Therapeutics
Employees1724
Total funding$17.4M$40.0M
Latest roundStrategic financingSeries A Extension
Valuation$1.1B$1.1B
LinkedIn followers1,2621,380

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

Measure4D PathDegron Therapeutics
StartupHub scoreOur 0-100 rating59/10062/100
Traction49/100Not published
Team70/10024/100
Search visibility39/10057/100
Quality68/100Not published
Agent readinessHow well an AI agent can read and act on the siteF (30/100)F (27/100)
Domain ratingLink authority, 0-1009/10024/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

Measure4D PathDegron Therapeutics
HostingNot detectedSelf Managed
CMSWordPressNot detected
FrameworksJquery, BootstrapNot detected

4D Path vs Degron Therapeutics: common questions

Which is better, 4D Path or Degron Therapeutics?

On our 0-100 score Degron Therapeutics rates higher (62/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do 4D Path and Degron Therapeutics compare on the numbers?

4D Path leads on agent readiness (30/100 against 27/100). Degron Therapeutics leads on domain rating (24/100 against 9/100), headcount (24 against 17), funding raised ($40.0M against $17.4M).

Read the full 4D Path review and pricing or the Degron Therapeutics review and pricing. You can also browse other 4D Path alternatives we track.